$0.000001
At close: Feb 26, 12:58 PM EDT
Comments
Loading...
TetraLogic Pharma Analyst Ratings and Price Targets | OTC:TLOG | Benzinga
TetraLogic Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for TetraLogic Pharma Corp from these most-recent analyst ratings.
Analyst Ratings for TetraLogic Pharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for TetraLogic Pharma (TLOG) stock?
There is no price target for TetraLogic Pharma
What is the most recent analyst rating for TetraLogic Pharma (TLOG)?
There is no analyst for TetraLogic Pharma
When was the last upgrade for TetraLogic Pharma (TLOG)?
There is no last upgrade for TetraLogic Pharma
When was the last downgrade for TetraLogic Pharma (TLOG)?
There is no last downgrade for TetraLogic Pharma.
When is the next analyst rating going to be posted or updated for TetraLogic Pharma (TLOG)?
There is no next analyst rating for TetraLogic Pharma.
Is the Analyst Rating TetraLogic Pharma (TLOG) correct?
There is no next analyst rating for TetraLogic Pharma.
Browse analyst ratings and price targets on all stocks.